Gamma-Aminobutyric Acid

Gamma-Aminobutyric Acid

SCHEMBL3789958

NC(Cc1c[nH]c2ccc([N+](=O)[O-])cc12)C(=O)O.NCCCC(=O)O.NCCCC(=O)O

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPRA P18433 1/20 0.68
CYP2C19 P33261 1/20 0.66
KMT2A Q03164 3/20 0.56
KDM4E B2RXH2 2/20 0.56
LMNA P02545 2/20 0.56
MAPT P10636 2/20 0.56
TSHR P16473 2/20 0.56
BLM P54132 2/20 0.56
PMP22 Q01453 2/20 0.56
ALDH1A1 P00352 1/20 0.56
CYP3A4 P08684 1/20 0.56
HTR1A P08908 1/20 0.56
ADORA3 P0DMS8 1/20 0.56
ALOX15 P16050 1/20 0.56
NFKB1 P19838 1/20 0.56
HTR2A P28223 1/20 0.56
HTR2C P28335 1/20 0.56
SLC6A4 P31645 1/20 0.56
HTR7 P34969 1/20 0.56
HTR2B P41595 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1580112 0.90 PTPRA (0.82) PTPRACYP2C19KMT2AKDM4ELMNA
SCHEMBL1580111 0.90 PTPRA (0.82) PTPRACYP2C19KMT2AKDM4ELMNA
SCHEMBL5115733 0.81 PTPRA (0.67) PTPRACYP2C19KMT2AKDM4ELMNA
SCHEMBL5115727 0.81 PTPRA (0.67) PTPRACYP2C19KMT2AKDM4ELMNA
SCHEMBL30381729 0.81 PTPRA (1.00) PTPRACYP2C19KMT2AKDM4ELMNA
SCHEMBL2965137 0.81 PTPRA (1.00) PTPRACYP2C19KMT2AKDM4ELMNA
SCHEMBL145392 0.81 PTPRA (1.00) PTPRACYP2C19KMT2AKDM4ELMNA
SCHEMBL3519524 0.81 PTPRA (1.00) PTPRACYP2C19KMT2AKDM4ELMNA
SCHEMBL30789181 0.81 PTPRA (1.00) PTPRACYP2C19KMT2AKDM4ELMNA
SCHEMBL14032218 0.79 PTPRA (0.60) PTPRACYP2C19KDM4EMAPTNQO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2398495-A1 MODIFIED NON-CYTOTOXIC PROTEASES Syntaxin Limited (GB) 2011-12-28 EP disclosed
WO-2010094905-A1 MODIFIED NON-CYTOTOXIC PROTEASES SYNTAXIN LIMITED (GB) 2010-08-26 WO disclosed
EP-1007070-A4 PROLONGING SURVIVAL OF TRANSPLANTED PANCREATIC CELLS BIOMEASURE INC (US) 2002-07-03 EP disclosed
EP-1007070-A1 PROLONGING SURVIVAL OF TRANSPLANTED PANCREATIC CELLS Biomeasure Incorporated (US) 2000-06-14 EP disclosed
EP-0980253-A1 SOMATOSTATIN AND SOMATOSTATIN AGONISTS FOR TREATING INSULIN INSENSITIVITY AND SYNDROME X SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) 2000-02-23 EP disclosed
WO-1998051332-A1 SOMATOSTATIN AND SOMATOSTATIN AGONISTS FOR TREATING INSULIN INSENSITIVITY AND SYNDROME X SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES S.A. (S.C.R.A.S.) (FR) 1998-11-19 WO disclosed
WO-1998008528-A1 METHOD OF INHIBITING FIBROSIS WITH A SOMATOSTATIN AGONIST BIOMEASURE INCORPORATED (US) 1998-03-05 WO disclosed
WO-1997037675-A1 PROLONGING SURVIVAL OF TRANSPLANTED PANCREATIC CELLS BIOMEASURE INCORPORATED (US) 1997-10-16 WO disclosed